CH BIOTECH SER (08037.HK) Announces Resignation of Executive Director He Xun
New Timespace News: China Biotech Services Holdings Limited (08037.HK) announced that Mr. He Xun has tendered his resignation as executive director due to needing to devote more energy to other business affairs, effective May 1, 2026. Mr. He has confirmed that there is no disagreement with the board of directors.
New Timespace News: China Biotech Services Holdings Limited (08037.HK) issued an announcement on April 30, 2026, disclosing the resignation of an executive director.
The announcement stated that Mr. He Xun has tendered his resignation as executive director due to needing to devote more energy to other business affairs, effective May 1, 2026. Mr. He has confirmed that there is no disagreement with the board of directors.
Tags：
- CH BIOTECH SER (08037.HK): Penbo (Hainan) BNCT hospital enters into cross-border oncology cooperation agreement with Hong Kong Oncare
- CH BIOTECH SER (08037.HK): Enters master cooperation agreement with Stella Pharma to develop and commercialize Steboronine®, world's first approved BNCT drug, in China
